Stockscreener 앱 받기
113.89
1.53%
1.715
Celcuity Inc 주식(CELC)의 최신 뉴스
Vanguard Group Inc. Raises Stock Position in Celcuity, Inc. $CELC - MarketBeat
CELC: Gedatolisib nears launch with strong trial data, regulatory momentum, and $10B+ peak potential - TradingView
TD Asset Management Inc Invests $3.60 Million in Celcuity, Inc. $CELC - MarketBeat
Artisan Partners Limited Partnership Boosts Stock Holdings in Celcuity, Inc. $CELC - MarketBeat
Celcuity Inc. (CELC) - DirectorsTalk Interviews
A Look At Celcuity (CELC) Valuation After Charles Romp Joins The Board And Gedatolisib Progress - simplywall.st
Celcuity To Participate in Upcoming Investor Conferences - The Manila Times
Celcuity Adds Oncology Veteran To Board As Gedatolisib Commercial Stakes Rise - Yahoo Finance
Bull Run: Should I set a stop loss on Celcuity IncJuly 2025 Opening Moves & Verified Swing Trading Watchlists - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (CELC) Movement - Stock Traders Daily
Is Celcuity’s (CELC) New Board Appointment a Turning Point for Its Commercial Strategy? - simplywall.st
Patient Square Capital LP Acquires Shares of 100,000 Celcuity, Inc. $CELC - MarketBeat
Soleus Adds a Significant Number of Celcuity Shares - AOL.com
Perceptive Advisors Increases Stake in Celcuity - Intellectia AI
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position - Yahoo Finance
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position - The Motley Fool
Avoro Capital Advisors LLC Acquires Significant Stake in Celcuit - GuruFocus
Avoro Capital Advisors LLC Acquires Significant Stake in Celcuity Inc - GuruFocus
Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator’s 9.29% Upside Captures Investor Attention - DirectorsTalk Interviews
Celcuity, Inc. (NASDAQ:CELC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Decliners Report: How does Celcuity Inc correlate with Nasdaq2025 Buyback Activity & Fast Momentum Entry Tips - baoquankhu1.vn
What Celcuity (CELC)'s Board Addition of Veteran Oncology Executive Means For Shareholders - Yahoo Finance
Commit To Purchase Celcuity At $45, Earn 17.8% Using Options - Nasdaq
Has Celcuity (CELC) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Soleus Capital Increases Stake in Celcuity - Intellectia AI
Is Celcuity’s New Oncology Commercial Leader Appointment Reshaping the Investment Case for CELC? - simplywall.st
Celcuity Adds Veteran Director to Strengthen Oncology Strategy - TipRanks
Ex-Seagen oncology exec joins Celcuity board for breast cancer drug push - Stock Titan
Discipline and Rules-Based Execution in CELC Response - Stock Traders Daily
Can Celcuity Inc. ride the EV waveJuly 2025 Outlook & Weekly Watchlist for Consistent Profits - mfd.ru
Celcuity CEO Sets July 17 PDUFA for Gedatolisib, Teases VIKTORIA-1 Mutant Data at Conference - MarketBeat
Celcuity at Guggenheim Summit: Biotech Innovations Unveiled By Investing.com - Investing.com Canada
CELC: Gedatolisib nears approval with strong efficacy, broad utility, and major commercial potential - TradingView
Candriam S.C.A. Increases Holdings in Celcuity, Inc. $CELC - MarketBeat
Celcuity, Inc. $CELC Stake Boosted by New York State Common Retirement Fund - MarketBeat
Inflation Data: Does Celcuity Inc align with a passive investing strategyJuly 2025 Pullbacks & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Published on: 2026-02-08 07:23:47 - baoquankhu1.vn
Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump - The Globe and Mail
Wall Street Recap: Is Celcuity Inc stock a smart retirement pickGold Moves & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Profit Review: Can Celcuity Inc ride the EV wave2025 Valuation Update & Breakout Confirmation Alerts - baoquankhu1.vn
Assessing Celcuity (CELC) Valuation After Recent Share Price Momentum And DCF Upside Estimate - Yahoo Finance
Wolfe Research recommends buying Celcuity stock on weakness related to external catalyst By Investing.com - Investing.com South Africa
Wolfe Research recommends buying Celcuity stock on weakness related to external catalyst - Investing.com Nigeria
Biotech Stocks To ResearchFebruary 4th - MarketBeat
Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Wealth Enhancement Advisory Services LLC Sells 10,476 Shares of Celcuity, Inc. $CELC - MarketBeat
3.97%
자본화:
|
볼륨(24시간):